Kodiak Sciences Inc (KOD) financial statements (2022 and earlier)

Company profile

Business Address 1200 PAGE MILL RD
PALO ALTO, CA 94304
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments73296933688
Cash and cash equivalents73294421288
Short-term investments 25125 
Other undisclosed current assets3332
Total current assets:73597233990
Noncurrent Assets
Operating lease, right-of-use asset67742
Property, plant and equipment41511
Long-term investments and receivables  12 
Long-term investments  12 
Restricted cash and investments6600
Other noncurrent assets551051
Total noncurrent assets:16995202
TOTAL ASSETS:9041,06735992
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6129115
Accounts payable12931
Accrued liabilities482094
Debt  0 
Other undisclosed current liabilities42  
Total current liabilities:6531125
Noncurrent Liabilities
Long-term debt and lease obligation76752 
Operating lease, liability76752
Liabilities, other than long-term debt0001
Other liabilities0001
Other undisclosed noncurrent liabilities100100  
Total noncurrent liabilities:17617521
Total liabilities:241207145
Stockholders' equity
Stockholders' equity attributable to parent66386134587
Common stock0000
Additional paid in capital1,2221,152503198
Accumulated other comprehensive income 00 
Accumulated deficit(558)(291)(158)(111)
Total stockholders' equity:66386134587
TOTAL LIABILITIES AND EQUITY:9041,06735992

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating expenses(267)(136)(49)(26)
Operating loss:(267)(136)(49)(26)
Nonoperating income (expense)(0)32(4)
Investment income, nonoperating032 
Foreign currency transaction loss, before tax(0)(0) (0)
Other nonoperating income (expense)(0)00(4)
Interest and debt expense(0)(0)(0)(11)
Loss from continuing operations before equity method investments, income taxes:(267)(133)(47)(42)
Other undisclosed income from continuing operations before income taxes00 0
Loss from continuing operations before income taxes:(267)(133)(47)(41)
Income tax expense(0)(0)  
Net loss available to common stockholders, diluted:(267)(133)(47)(41)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(267)(133)(47)(41)
Comprehensive loss:(267)(133)(47)(41)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)00 
Comprehensive loss, net of tax, attributable to parent:(267)(133)(47)(41)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: